← Back to Search

Polyphenol Supplement

Tart Cherry Supplement for Metabolic Syndrome

N/A
Recruiting
Research Sponsored by Ohio University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have been diagnosed with metabolic syndrome by a physician or meet the diagnostic criteria: Waist circumference greater than 40 inches (men) or greater than 35 inches (women), High blood pressure (greater than 130/80) or taking medication for high blood pressure, High triglycerides (greater than 150 mg/dL) or low HDL (less than 40 for men, less than 50 for women), High fasting blood glucose (100-126 mg/dL) or diagnosed as pre-diabetic
Age 25-60
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 30 days post supplementation, 60 days post supplmentation
Awards & highlights

Study Summary

This trial aims to test the effects of tart cherry supplements on MetSyn, a growing health concern linked to cardiovascular diseases & type II diabetes, with treatment including exercise & weight loss.

Who is the study for?
This trial is for adults aged 25-60 with metabolic syndrome, characterized by a large waistline, high blood pressure or medication use for it, abnormal cholesterol levels, and elevated fasting blood sugar. Participants should not have inflammatory conditions, be on anti-inflammatory meds or steroids recently, have major organ failure, smoke currently or quit within the last year.Check my eligibility
What is being tested?
The study tests if powdered tart cherry supplements can improve metabolic syndrome over 60 days. It compares the effects of these supplements to a placebo (a substance with no therapeutic effect) on body mass, waist size, blood pressure, lipid levels and glucose control in participants.See study design
What are the potential side effects?
While specific side effects are not listed for powdered tart cherry supplements in this context; generally such natural products may cause digestive discomfort or allergic reactions in some individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with metabolic syndrome or meet its criteria.
Select...
I am between 25 and 60 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 30 days post supplementation, 60 days post supplmentation
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 30 days post supplementation, 60 days post supplmentation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight Changes
Change in body fat distribution
Blood Sedimentation
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: tart cherryExperimental Treatment1 Intervention
two capsules daily for 60 days
Group II: placeboPlacebo Group1 Intervention
two capsules daily for 60 days

Find a Location

Who is running the clinical trial?

Ohio UniversityLead Sponsor
69 Previous Clinical Trials
37,184 Total Patients Enrolled

Media Library

Metabolic Syndrome Research Study Groups: tart cherry, placebo

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cumulative participant count for this investigation?

"Indeed, the data posted to clinicaltrials.gov clearly states that this trial is still recruiting patients as of November 7th 2022. It was initially published on April 6th and requires 30 individuals from a single medical centre."

Answered by AI

What criteria must an individual fulfill in order to be accepted into this experiment?

"This trial seeks to recruit thirty individuals with metabolic syndrome, ranging from 18 to 60 years of age. To qualify for the study, participants must have a waist circumference higher than 40 inches (if male) or above 35 inches (female), blood pressure greater than 130/80 mmHg or be taking medication for high blood pressure, triglycerides levels surpassing 150 mg/dL and HDL below 40mg/dl in men and 50mg/dl in women; additionally, fasting glucose should be between 100-126 mg/dL or diagnose as pre-diabetic."

Answered by AI

Is this clinical investigation enrolling senior citizens?

"This clinical trial is geared towards patients between 18 and 60 years of age; however, there are other trials for those under 18 (382) or over 65 (1045)."

Answered by AI

Are additional participants being admitted to this research endeavor?

"Data collected on clinicaltrials.gov confirms that this trial is still actively recruiting participants, having been initially posted on April 6th 2022 and last updated November 7th of the same year."

Answered by AI
~2 spots leftby Jun 2024